scispace - formally typeset
S

Sameh Hany Emile

Researcher at Mansoura University

Publications -  255
Citations -  2594

Sameh Hany Emile is an academic researcher from Mansoura University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 180 publications receiving 1351 citations.

Papers
More filters
Journal ArticleDOI

Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study

Mauro Podda, +567 more
- 11 Mar 2023 - 
TL;DR: In this article , the authors conducted a post hoc analysis of the MANCTRA-1 international study to assess the association between clinical risk factors and mortality among adult patients with IPN.
Journal ArticleDOI

How reliable is restaging MRI after neoadjuvant therapy in rectal cancer?

TL;DR: In this article , the authors compared findings of preoperative, post-neoadjuvant MRI with final pathology relative to T stage, N stage, tumour size, and circumferential resection margin (CRM) status.
Journal ArticleDOI

Follow-up MRI in the postoperative assessment of anal fistulas; Is it a necessity or luxury?

TL;DR: In this paper, the role of MRI in the confirmation of healing of anal fistulas was discussed and a well-designed study that sheds light on an important aspect of care of patients with anal fistula, the postoperative follow-up.
Journal ArticleDOI

Meta-Analysis of Randomized Clinical Trials on Long-Term Outcomes of Surgical Treatment of Perforated Diverticulitis.

TL;DR: In this article , the authors evaluated long-term outcomes of patients with perforated diverticulitis treated with resection or laparoscopic lavage (LL) and found that LL had lower odds of longterm ostomy, long term complications, recurrence, and re-intervention rates.
Journal ArticleDOI

When is neoadjuvant chemotherapy indicated in rectal neuroendocrine tumors? An analysis of the National Cancer Database.

TL;DR: In this article , the role of chemotherapy in general and neoadjuvant therapy specifically in managing advanced rectal neuroendocrine tumors (rNETs) has not been well established.